HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of safety and efficacy of purgative manna (billinaster drop) and glycerin suppository in icterus of healthy term newborns.

AbstractOBJECTIVE:
The aim of the present study was to investigate safety and efficacy of billinaster drop and glycerin suppository in hyperbilirubinemia of healthy term newborns who had passage of first meconium.
METHODS:
In a randomized clinical trial, 90 neonates with total plasma bilirubin(TPB) level of 15-20mg/dL, were randomly assigned to be treated with alone phototherapy (control) or 5drop/kg of bilinaster drop every eight hours and phototherapy(B) or half of glycerin suppository every twelve hours and phototherapy(G). The primary outcomes were safety of drugs and efficacy in obtaining TPB of less than 14 mg/dL as measured at the beginning, 12, 24 and 48 hours after intervention. Secondary endpoint was hospitalization days.
RESULTS:
After 48 hours of intervention, achieving TPB of less than 14 mg/dL was seen in 50 %( N=15) in control group, 73.3 %( N=22) in B group and 86.7 %( N=26 neonates) in G group (P= 0.01). Watery stool was seen in two neonates of glycerin group and safety of the treatments was not significantly different. Mean of TPB 12 hours after beginning of phototherapy(mean±SD:14.38±2.27mg/dL in G, 15.97±1.96mg/dL in B and 16.67±1.77mg/dL in control), 24 hours after intervention(mean±SD:12.56 ±1.59mg/dL in G, 12.57±2.05mg/dL in B and 14.36±2.26mg/dL in control), 48 hours after intervention (mean±SD: 9.34 ± 1.6mg/dL in G, 9.96 ± 2.95mg/dL in B and 12.27 ± 2.4mg/dL in control) and mean of hospitalization days (mean± SD: 1.5 ± 0.4days in G, 1.7 ± 0.4days in B and 2.9 ± 1.1days in control) were significantly lower in glycerin and billinaster groups.
CONCLUSION:
Bilinaster drop and glycerin suppository can be used as hazardless, efficient and cost effective drugs in treatment of neonatal hyperbilirubinemia.
AuthorsRazieh Fallah, Mohammad Ali Fallahzadeh, Mahmood Noori-Shadkam
JournalCurrent drug safety (Curr Drug Saf) Vol. 9 Issue 1 Pg. 29-33 (Mar 2014) ISSN: 2212-3911 [Electronic] United Arab Emirates
PMID24111649 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Cathartics
  • Complex Mixtures
  • Suppositories
  • purgative manna
  • Glycerol
  • Bilirubin
Topics
  • Bilirubin (analysis)
  • Cathartics (administration & dosage, adverse effects, therapeutic use)
  • Complex Mixtures (administration & dosage, adverse effects, therapeutic use)
  • Double-Blind Method
  • Endpoint Determination
  • Female
  • Glycerol (administration & dosage, adverse effects, therapeutic use)
  • Humans
  • Hyperbilirubinemia, Neonatal (drug therapy)
  • Infant, Newborn
  • Jaundice (drug therapy, therapy)
  • Length of Stay
  • Male
  • Phototherapy
  • Single-Blind Method
  • Suppositories

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: